JAMA: 2012-11-28, Vol. 308, No. 20, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Release Date: 01/17/2013
JAMA: 2013-02-27, Vol. 309, No. 8, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Justin B. Dimick, MD, MPH, author of Bariatric Surgery Complications Before vs After Implementation of a National Policy Restricting Coverage to Centers of Excellence. Summary Points:...
info_outline
JAMA: 2013-03-20, Vol. 309, No. 11, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Phillip M. Boiselle, MD, author of Computed Tomography Screening for Lung Cancer. Summary Points:
info_outline
JAMA: 2013-02-20, Vol. 309, No. 7, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Daniel J. Buysse, MD, author of Insomnia. Summary Points:
info_outline
JAMA: 2013-01-16, Vol. 309, No. 3, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Daniel S. Chertow, MD, MPH, author of Bacterial Coinfection in Influenza: A Grand Rounds Review. Summary Points:
info_outline
JAMA: 2012-11-28, Vol. 308, No. 20, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Robert H. Shmerling, MD, author of Management of Gout: A 57-Year-Old Man With a History of Podagra, Hyperuricemia, and Mild Renal Insufficiency. Summary Points:...
info_outline
JAMA: 2012-11-21, Vol. 308, No. 19, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Laura N. Gitlin, PhD, author of Nonpharmacologic Management of Behavioral Symptoms in Dementia. Summary Points:
info_outline
JAMA: 2012-10-17, Vol. 308, No. 15, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Nancy A. Rigotti, MD, author of Strategies to Help a Smoker Who Is Struggling to Quit. Summary Points:
info_outline
JAMA: 2012-10-03, Vol. 308, No. 13, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Robert W. Haley, MD, author of Controlling Urban Epidemics of West Nile Virus Infection. Summary Points:...
info_outline
JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview
Author in the Room™ Interviews
Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:...
info_outline
Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel
Author in the Room™ Interviews
Interview with Melanie A. Thompson, MD, and Paul A. Volberding, MD, authors of Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel. Summary Points: Antiretroviral treatment is recommended and should be offered to all persons with HIV, regardless of CD4 cell count. Particular attention should be paid to the design of an antiretroviral regimen for persons with concurrent conditions, such as viral hepatitis, opportunistic infections, and other medical diseases, because of the potential for drug interactions. Monitoring of entry...
info_outlineInterview with Robert H. Shmerling, MD, author of Management of Gout: A 57-Year-Old Man With a History of Podagra, Hyperuricemia, and Mild Renal Insufficiency. Summary Points:
- Risk factor modification: alcohol intake, excess weight, diet, medications (although overall impact on gout uncertain).
- Acute gout can be treated with NSAIDs, colchicine, corticosteroids, or a combination of these.
- Urate-lowering treatment to prevent attacks and tophi is appropriate for certain patients with gout. (In my opinion, allopurinol is the best initial choice to suppress uric acid.)
- Urate-lowering treatment should suppress uric acid to 6.0 mg/dL or less; allopurinol should start no higher than 100 mg/d but titrate up based on uric acid levels; it is common to require more than 300 mg/d.
- Concomitant prophylaxis (eg, low-dose colchicine, 0.6 mg/d) is appropriate for 6-9 months or longer.
Take home message:
We now have new therapies and guidelines for the treatment of gout. Appropriate use of therapeutics for gout—both new and old—will provide optimal outcomes for the increasing number of patients with this common disease.